Infections in patients with cystic fibrosis: diagnostic microbiology update
- PMID: 24856524
- PMCID: PMC7115738
- DOI: 10.1016/j.cll.2014.02.001
Infections in patients with cystic fibrosis: diagnostic microbiology update
Abstract
Survival has improved in patients with cystic fibrosis (CF), in part because of aggressive antimicrobial management. Two multidrug-resistant environmental bacteria, the Burkholderia cepacia group and nontuberculous mycobacteria, have emerged. Improving genomic and proteomic technologies are allowing better identification of bacteria and fungi found in the CF lung and detection of viral agents that may be associated with pulmonary exacerbations. Anaerobic bacteria and Streptococcus angionsus group organisms may play a role in chronic CF lung infections. The diversity of organisms declines perhaps as a result of aggressive antimicrobial therapy, and an apex predator, Pseudomonas aeruginosa, may emerge in many patients with CF.
Keywords: Cystic fibrosis; Diagnostic microbiology; Infection; Update.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures
References
-
- ACOG Committee Opinion No. 486: update on carrier screening for cystic fibrosis. Obstet Gynecol. 2011;117:1028–1031. - PubMed
-
- Donaldson S.H., Wolgang M.C., Gilligan P.G. Cystic fibrosis. In: Mandell G.L., Bennett J.E., Dolin R., editors. Principles and practices of infectious diseases. 7th edition. Churchill Livingstone; New York: 2006. pp. 947–955.
-
- Cystic Fibrosis Foundation. Cystic Fibrosis Foundation patient registry 2012 annual data report. 2013.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
